GSK (GSK LN) receives US FDA NVDA supplemental 15 approval for Wellcovorin
Importance
Level 1
#UNITED KINGDOM#EUROPE#NVIDIA CORP#GLAXOSMITHKLINE PLC#GSK.LN#FDA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#SEMICONDUCTORS#PHARMACEUTICALS (GROUP)#SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#SEMICONDUCTORS & SEMICONDUCTOR EQUIPMENT#S&P 500 INDEX#NASDAQ 100 INDEX#FTSE 100 INDEX#NVDA#GSK PLC#GSK#US EQUITIES#FTSE 100